Mind-NRG ^None

Mind-NRG is a Swiss company that specializes in developing NRG-101, a neurotrophic factor that can treat psychiatric and neurologic diseases. NRG-101 can cross the blood-brain barrier and target the brain to treat disorders like Parkinson's disease, Alzheimer's disease, and schizophrenia. The company will conduct experiments to understand the mechanism of action of the peptide and assess its activity in various disease models.